Axxion S.A.’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding IOVA
Axxion S.A.'s IOVA Position: Q3 2026 in Review
Axxion S.A. sold out of Iovance Biotherapeutics (IOVA) in Q3 2026, closing a stake of 100,000 shares — an estimated $416K sold.
Axxion S.A. first reported a position in IOVA in Q2 2026 and held it in 1 quarter. The position peaked at $416K in Q2 2026. 253 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.
- Axxion S.A. reported no remaining Iovance Biotherapeutics position as of Q3 2026 after selling out during the quarter.
- Axxion S.A. sold 100,000 Iovance Biotherapeutics shares in Q3 2026, an estimated $416K.
- Axxion S.A. first reported a position in Iovance Biotherapeutics in Q2 2026 and held it in 1 quarter.
- Axxion S.A.'s Iovance Biotherapeutics position peaked at $416K in Q2 2026.
- 253 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.
Based on Axxion S.A.'s 13F filing for Q3 2026, filed 22 Oct 2026.